Xueqin Wu

837 total citations · 1 hit paper
27 papers, 609 citations indexed

About

Xueqin Wu is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xueqin Wu has authored 27 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Nephrology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xueqin Wu's work include Acute Kidney Injury Research (5 papers), Chronic Kidney Disease and Diabetes (3 papers) and Vibrio bacteria research studies (2 papers). Xueqin Wu is often cited by papers focused on Acute Kidney Injury Research (5 papers), Chronic Kidney Disease and Diabetes (3 papers) and Vibrio bacteria research studies (2 papers). Xueqin Wu collaborates with scholars based in China, Australia and United States. Xueqin Wu's co-authors include Hao Zhang, Shikun Yang, Wei Zhang, Zhaoxin Hu, Aimei Li, Dong He, Ke Cao, Ming Yang, Yachun Han and Ming Zhan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The FASEB Journal.

In The Last Decade

Xueqin Wu

23 papers receiving 604 citations

Hit Papers

AMPK agonist alleviate renal tubulointerstitial fibrosis ... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueqin Wu China 12 282 146 109 97 87 27 609
Hairong Zhao China 14 259 0.9× 101 0.7× 104 1.0× 160 1.6× 95 1.1× 42 587
Fuqiang Liu China 17 224 0.8× 72 0.5× 86 0.8× 50 0.5× 85 1.0× 82 786
A Yoshida Japan 9 263 0.9× 115 0.8× 100 0.9× 77 0.8× 72 0.8× 21 704
Marian Bulthuis Netherlands 16 194 0.7× 101 0.7× 83 0.8× 57 0.6× 40 0.5× 40 705
Chunxia Shi China 16 466 1.7× 124 0.8× 211 1.9× 57 0.6× 108 1.2× 39 865
Zijing Zhu China 18 402 1.4× 52 0.4× 114 1.0× 229 2.4× 112 1.3× 45 789
Shirong Cao United States 15 254 0.9× 106 0.7× 170 1.6× 240 2.5× 30 0.3× 23 690
Waleed Mohamed Egypt 14 121 0.4× 112 0.8× 178 1.6× 34 0.4× 76 0.9× 33 597
Yanhua Zhao China 12 241 0.9× 46 0.3× 61 0.6× 172 1.8× 73 0.8× 28 611

Countries citing papers authored by Xueqin Wu

Since Specialization
Citations

This map shows the geographic impact of Xueqin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqin Wu more than expected).

Fields of papers citing papers by Xueqin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqin Wu. The network helps show where Xueqin Wu may publish in the future.

Co-authorship network of co-authors of Xueqin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xueqin Wu. A scholar is included among the top collaborators of Xueqin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueqin Wu. Xueqin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Jinrong, et al.. (2025). Tubular specific glutathione peroxidase 3 deletion exacerbates kidney damage in IRI-AKI mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(6). 167895–167895.
3.
Wei, Li, Yu Feng, Xia Kang, et al.. (2024). Handwashing sinks as reservoirs of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: a prospective multicenter study. Frontiers in Public Health. 12. 1468521–1468521. 3 indexed citations
4.
Tang, Shiqi, Xueqin Wu, Qing Dai, et al.. (2023). Vitamin D receptor attenuate ischemia-reperfusion kidney injury via inhibiting ATF4. Cell Death Discovery. 9(1). 158–158. 9 indexed citations
5.
Li, Dan, Ni Yin, Xueqin Wu, et al.. (2023). tRNA-Derived Small RNAs: A Novel Regulatory Small Noncoding RNA in Renal Diseases. SHILAP Revista de lepidopterología. 10(1). 1–11. 3 indexed citations
6.
Peng, Jie, Pei Ma, Xueqin Wu, et al.. (2023). A case-control study and systematic review of the association between glutathione S-transferase genes and chronic kidney disease. Heliyon. 9(11). e21183–e21183. 3 indexed citations
7.
Meng, Ting, Joshua D. Ooi, Peter J. Eggenhuizen, et al.. (2023). Development of a radiomics nomogram to predict the treatment resistance of Chinese MPO-AAV patients with lung involvement: a two-center study. Frontiers in Immunology. 14. 1084299–1084299. 1 indexed citations
8.
Wu, Xueqin, Jingyi Li, & Wenjing Du. (2022). Causes of death following small cell lung cancer diagnosis: a population-based analysis. BMC Pulmonary Medicine. 22(1). 262–262. 8 indexed citations
9.
Li, Aimei, Wei Zhang, Xueqin Wu, et al.. (2022). ATP-citrate lyase inhibitor improves ectopic lipid accumulation in the kidney in a db/db mouse model. Frontiers in Endocrinology. 13. 914865–914865. 9 indexed citations
10.
Li, Min, Xueqin Wu, Xiaotian Niu, et al.. (2022). Dietary α-lipoic acid alleviates deltamethrin-induced immunosuppression and oxidative stress in northern snakehead (Channa argus) via Nrf2/NF-κB signaling pathway. Fish & Shellfish Immunology. 127. 228–237. 22 indexed citations
11.
Wu, Xueqin, Yong Zhong, Ting Meng, et al.. (2022). Patient Survival Between Hemodialysis and Peritoneal Dialysis Among End-Stage Renal Disease Patients Secondary to Myeloperoxidase-ANCA-Associated Vasculitis. Frontiers in Medicine. 8. 775586–775586. 4 indexed citations
12.
Li, Dan, Hao Zhang, Xueqin Wu, et al.. (2022). Role of tRNA derived fragments in renal ischemia–reperfusion injury. Renal Failure. 44(1). 815–825. 12 indexed citations
13.
Zhu, Binghua, Jing Tang, Rong Fang, et al.. (2021). Pulmonary coinfection of Mycobacterium tuberculosis and Tropheryma whipplei: a case report. Journal of Medical Case Reports. 15(1). 359–359. 10 indexed citations
14.
Han, Yachun, Shiqi Tang, Yuting Liu, et al.. (2021). AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death and Disease. 12(10). 925–925. 163 indexed citations breakdown →
15.
Shen, Heping, Diying Shen, Hua Song, et al.. (2020). Clinical assessment of the utility of metagenomic next‐generation sequencing in pediatric patients of hematology department. International Journal of Laboratory Hematology. 43(2). 244–249. 28 indexed citations
16.
Yang, Shikun, Yachun Han, Jinrong He, et al.. (2020). Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway. Biomedicine & Pharmacotherapy. 130. 110521–110521. 69 indexed citations
17.
Hu, Zhaoxin, Hao Zhang, Shikun Yang, et al.. (2019). Emerging Role of Ferroptosis in Acute Kidney Injury. Oxidative Medicine and Cellular Longevity. 2019. 1–8. 143 indexed citations
18.
Wang, Yang, Ying Lei, Keke Jin, et al.. (2018). Adenosine A(2A) receptor activation reverses hypoxia‑induced rat pulmonary artery smooth muscle cell proliferation via cyclic AMP‑mediated inhibition of the SDF1‑CXC4 signaling pathway. International Journal of Molecular Medicine. 42(1). 607–614. 4 indexed citations
19.
Wang, Dan, Li Zhu, Shulian Zhang, et al.. (2016). Predictive macrosomia birthweight thresholds for adverse maternal and neonatal outcomes. The Journal of Maternal-Fetal & Neonatal Medicine. 29(23). 3745–3750. 14 indexed citations
20.
Xu, Yajie, Xueqin Wu, Wei Liu, et al.. (2002). A convenient assay of glycoserum by nitroblue tetrazolium with iodoacetamide. Clinica Chimica Acta. 325(1-2). 127–131. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026